Warburg Pincus is close to acquiring specialty pharmacy company Pantherx Rare in a transaction valued at more than $7bn, including debt, according to a report by the Wall Street Journal citing unnamed people familiar with the matter.
The private equity firm is expected to partner with the Abu Dhabi Investment Authority (ADIA) on the acquisition, continuing a relationship that has seen the two investors collaborate on previous transactions.
Pantherx Rare, headquartered in Pittsburgh, specialises...
Continue Reading
Sign up for FREE to read the full article and access 148K+ alternative investment headlines.